🔗 Permalink

Inventor profile of:

David Sidransky

City:

Baltimore, Maryland

Country:

United States

Published Applications:

Last publication date:

2022-06-16

Top Assignees for applications by David Sidransky

The entities that hold a legal rights for patent applications filed by inventor Sidransky David:

THE JOHNS HOPKINS UNIVERSITY 18 Baltimore, MD United States
THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE 7 Baltimore, MD United States
JOHNS HOPKINS UNIVERSITY 3 Baltimore, MD United States
The U.S.A. as represented by the Secretary of the HHS 1 Rockville, MD United States
Genzyne Corporation 1 Cambridge, MA United States
Esoterix Genetic Laboratories, LLC 1 Burlington, NC United States
Champions Biotechnology, Inc 1 HACKENSACK, NJ United States
The United States of America as Represented by the Department of Health and Human Services 1 Washington, DC United States
Genzyme Corporation 1 Cambridge, MD United States
The United States of America as Represented by the Secretary of Health and Human Services 1 Rockville, MD United States
THE JOHNS HOPKINS UNIVERSITY 1 Baltimore, -
The Johns Hopkins University School of Medical 1 Baltimore, MD United States
Genzyme Corporation 1 Framingham, MA United States
Genzyme Corporation 1 Cambridge, MA United States
ZILA BIOTECHNOLOGY, INC. 1 Phoenix, AZ United States
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE 1 Baltimore, MD United States
The John Hopkins University School of Medicine 1 Baltimore, MD United States
ONCOMETHYLOME SCIENCES SA 1 Sart-Tilman (Liege), Belgium
The Johns Hopkins University of Medicine 1 Baltimore, MD United States
Oncomethylome Sciences, S.A. 1 Liege, Belgium

Recent patent applications by Sidransky David

David Sidransky from Baltimore, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-06-16

US20220184037A1

Human necessities

PHARMACEUTICAL AGENTS TARGETING CANCER STEM CELLS

#2 | 2019-03-28

US20190091202A1

Human necessities

Pharmaceutical agents targeting cancer stem cells

#3 | 2018-12-20

US20180363063A1

Chemistry; metallurgy

Method to use viral and host methylation markers for cervical cancer screening and triage in liquid prep, serum/plasma, and urine: PCR and sequencing based process methods

#4 | 2018-08-09

US20180223338A1

Chemistry; metallurgy

MICROBIOME IDENTIFICATION AND USE IN DIAGNOSIS OF HEAD AND NECK SQUAMOUS CELL CANCER

#5 | 2017-09-21

US20170268059A1

Chemistry; metallurgy

DNA HYPERMETHYLATION OF PROMOTERS OF TARGET GENES AND CLINICAL DIAGNOSIS AND TREATMENT OF HPV RELATED DISEASE

#6 | 2017-08-17

US20170233817A1

Chemistry; metallurgy

16S RRNA SALIVA ANALYSIS UNVEILS MICROBIOME BIOMONITORS LINKED TO HUMAN PAPILLOMA VIRUS AND OROPHARYNGEAL SQUAMOUS CELL CARCINOMA

#7 | 2017-06-22

US20170175201A1

Chemistry; metallurgy

TGF(β)-MIR200-MIG6 pathway and its use in the treatment of cancer as an indicator of resistance to EGFR inhibitors

#8 | 2017-05-04

US20170118965A1

Human necessities

HUMANIZED MOUSE MODELS AND USES THEREOF

#9 | 2016-09-01

US20160251726A1

Chemistry; metallurgy

Hypermethylation biomarkers associated with poor survival outcomes for head and neck squamous cell cancer

#10 | 2016-01-14

US20160010163A1

Chemistry; metallurgy

Dual sequence-capture method for quantifying trans renal HPV DNA in urine

#11 | 2015-02-19

US20150051100A1

Chemistry; metallurgy

DNA HYPERMETHYLATION OF PROMOTERS OF TARGET GENES AND CLINICAL DIAGNOSIS AND TREATMENT OF HPV RELATED DISEASE

#12 | 2015-02-12

US20150045241A1

Chemistry; metallurgy

GLOBAL DNA HYPOMETHYLATION AND BIOMARKERS FOR CLINICAL INDICATIONS IN CANCER

#13 | 2014-05-22

US20140141998A1

Chemistry; metallurgy

NEOPLASIA SCREENING COMPOSITIONS AND METHODS OF USE

#14 | 2013-07-25

US20130190310A1

Chemistry; metallurgy

MIG6 AND THERAPEUTIC EFFICACY

#15 | 2013-05-02

US20130109584A1

Chemistry; metallurgy

Hypermethylation biomarkers for detection of cervical cancer

#16 | 2013-03-21

US20130071842A1

Chemistry; metallurgy

Hypermethylation biomarkers for detection of head and neck squamous cell cancer

#17 | 2013-02-07

US20130035247A1

Chemistry; metallurgy

Global DNA hypomethylation and biomarkers for clinical indications in cancer

#18 | 2011-04-21

US20110091892A1

Chemistry; metallurgy

Methods for the diagnosis and treatment of lung cancer

#19 | 2010-09-14

US10384491

Genomic screen for epigenetically silenced genes associated with cancer

#20 | 2010-08-24

US10383864

Genomic screen for epigenetically silenced tumor suppressor genes

#21 | 2010-03-11

US20100062443A1

Chemistry; metallurgy

Methods for the diagnosis and treatment of lung cancer

#22 | 2010-02-11

US20100035970A1

Chemistry; metallurgy

Methylation Markers for Diagnosis and Treatment of Cancers

#23 | 2009-11-19

US20090286236A1

Chemistry; metallurgy

Method for detecting cell proliferative disorders

#24 | 2009-10-29

US20090270265A1

Chemistry; metallurgy

Molecular characteristics of non-small cell lung cancer

#25 | 2009-08-27

US20090215709A1

Chemistry; metallurgy

Methylation markers for diagnosis and treatment of cancers

#26 | 2009-07-16

US20090181400A1

Chemistry; metallurgy

Method of Detection of Prostate Cancer

#27 | 2009-05-14

US20090124795A1

Chemistry; metallurgy

Mitochondrial Dosimeter

#28 | 2009-02-26

US20090054260A1

Chemistry; metallurgy

Neoplasia screening compositions and methods of use

#29 | 2009-01-22

US20090023138A1

Chemistry; metallurgy

ORAL CANCER MARKERS AND THEIR DETECTION

#30 | 2009-01-22

US20090023134A1

Chemistry; metallurgy

Neoplasia diagnostic compositions and methods of use

#31 | 2008-12-23

US10274874

protein acts as an oncogene

#32 | 2008-10-02

US20080241132A1

Chemistry; metallurgy

mutation T1796A in thyroid cancers

#33 | 2008-05-29

US20080124729A1

Chemistry; metallurgy

Detection of nucleic acid mutation associated with cancer by analysis of saliva

#34 | 2008-01-31

US20080026395A1

Chemistry; metallurgy

Method of detection of prostate cancer

#35 | 2008-01-15

US10290473

Detection of hypermutable nucleic acid sequence in tissue

#36 | 2007-09-20

US20070218511A1

Chemistry; metallurgy

Methods for the diagnosis and treatment of lung cancer

#37 | 2007-08-07

US10295483

Method of detection of prostate cancer

#38 | 2005-09-08

US20050196773A1

Physics

Predicting upper aerodigestive tract cancer

#39 | 2005-06-23

US20050136403A1

Chemistry; metallurgy

Molecular characteristics of non-small cell lung cancer

#40 | 2005-05-05

US20050095621A1

Chemistry; metallurgy

Method for detecting cell proliferative disorders

#41 | 2005-03-03

US20050048533A1

Chemistry; metallurgy

BRAF mutation T1796A in thyroid cancers

#42 | 2005-01-13

US20050009040A1

Chemistry; metallurgy

Nucleic acid mutation detection by analysis of saliva

InventorID:

79699 ⎘